News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
228,575 Results
Type
Article (13508)
Company Profile (33)
Press Release (215034)
Multimedia
Podcasts (10)
Webinars (6)
Section
Business (63382)
Career Advice (699)
Deals (15048)
Drug Delivery (30)
Drug Development (31997)
Employer Resources (70)
FDA (5566)
Job Trends (4998)
News (117170)
Policy (9869)
Tag
2024 BioMidwest Digital (2)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (2)
2024 Pharm Country Standard (2)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (1126)
Academic (1)
Accelerated approval (1)
Adcomms (6)
Allergies (33)
Alliances (17903)
ALS (44)
Alzheimer's disease (520)
Antibody-drug conjugate (ADC) (25)
Approvals (5588)
Artificial intelligence (66)
Autoimmune disease (8)
Automation (5)
Bankruptcy (129)
Best Places to Work (4219)
BIOSECURE Act (6)
Biosimilars (37)
Biotechnology (18)
Bladder cancer (25)
Brain cancer (9)
Breast cancer (95)
Cancer (713)
Cardiovascular disease (68)
Career advice (588)
Career pathing (13)
CAR-T (46)
Cell therapy (121)
Cervical cancer (10)
Clinical research (27123)
Collaboration (216)
Compensation (37)
Complete response letters (1)
COVID-19 (1132)
CRISPR (8)
C-suite (71)
Cystic fibrosis (29)
Data (861)
Denatured (7)
Depression (11)
Diabetes (111)
Diagnostics (2193)
Digital health (4)
Diversity (5)
Diversity, equity & inclusion (28)
Drug discovery (40)
Drug pricing (41)
Drug shortages (16)
Duchenne muscular dystrophy (31)
Earnings (19806)
Editorial (16)
Employer branding (6)
Employer resources (64)
Events (28489)
Executive appointments (253)
FDA (5984)
Featured Employer (13)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (262)
Gene editing (20)
Generative AI (6)
Gene therapy (89)
GLP-1 (283)
Government (1315)
Grass and pollen (2)
Guidances (13)
Healthcare (6764)
Huntington's disease (6)
IgA nephropathy (9)
Immunology and inflammation (34)
Indications (8)
Infectious disease (1185)
Inflammatory bowel disease (58)
Inflation Reduction Act (4)
Influenza (20)
Intellectual property (27)
Interviews (122)
IPO (7091)
IRA (19)
Job creations (928)
Job search strategy (511)
Kidney cancer (2)
Labor market (7)
Layoffs (83)
Leadership (7)
Legal (2251)
Liver cancer (23)
Lung cancer (93)
Lymphoma (48)
Machine learning (2)
Management (22)
Manufacturing (80)
MASH (37)
Medical device (4457)
Medtech (4459)
Mergers & acquisitions (8300)
Metabolic disorders (250)
Multiple sclerosis (39)
NASH (15)
Neurodegenerative disease (23)
Neuropsychiatric disorders (4)
Neuroscience (729)
NextGen: Class of 2025 (2599)
Non-profit (1720)
Northern California (713)
Obesity (114)
Opinion (48)
Ovarian cancer (20)
Pain (38)
Pancreatic cancer (33)
Parkinson's disease (66)
Partnered (9)
Patents (62)
Patient recruitment (41)
Peanut (18)
People (21457)
Pharmaceutical (11)
Pharmacy benefit managers (10)
Phase I (6518)
Phase II (11796)
Phase III (10653)
Pipeline (389)
Policy (54)
Postmarket research (1212)
Preclinical (2368)
Press Release (30)
Prostate cancer (39)
Psychedelics (9)
Radiopharmaceuticals (97)
Rare diseases (128)
Real estate (1786)
Recruiting (23)
Regulatory (7046)
Reports (18)
Research institute (984)
Resumes & cover letters (95)
Rett syndrome (1)
RSV (20)
Schizophrenia (32)
Series A (52)
Series B (32)
Service/supplier (2)
Sickle cell disease (20)
Southern California (723)
Special edition (2)
Spinal muscular atrophy (63)
Sponsored (5)
Startups (1497)
State (1)
Stomach cancer (5)
Supply chain (19)
Tariffs (7)
The Weekly (3)
United States (7145)
Vaccines (293)
Venture capitalists (8)
Weight loss (71)
Women's health (15)
Worklife (6)
Date
Today (49)
Last 7 days (179)
Last 30 days (786)
Last 365 days (10933)
2025 (3249)
2024 (11704)
2023 (13585)
2022 (17654)
2021 (19990)
2020 (19458)
2019 (17287)
2018 (13331)
2017 (12266)
2016 (11334)
2015 (13916)
2014 (9627)
2013 (7606)
2012 (8193)
2011 (8233)
2010 (7178)
Location
Africa (264)
Alabama (8)
Alaska (4)
Arizona (60)
Arkansas (3)
Asia (14932)
Australia (2618)
California (1764)
Canada (481)
China (167)
Colorado (69)
Connecticut (88)
Delaware (45)
Europe (36236)
Florida (275)
Georgia (88)
Idaho (20)
Illinois (183)
India (11)
Indiana (123)
Iowa (2)
Japan (73)
Kansas (43)
Kentucky (7)
Louisiana (6)
Maine (46)
Maryland (293)
Massachusetts (1155)
Michigan (90)
Minnesota (115)
Mississippi (2)
Missouri (24)
Montana (7)
Nebraska (6)
Nevada (30)
New Hampshire (17)
New Jersey (640)
New Mexico (9)
New York (648)
North Carolina (324)
Northern California (713)
Ohio (62)
Oklahoma (3)
Oregon (6)
Pennsylvania (439)
Puerto Rico (3)
Rhode Island (6)
South America (413)
South Carolina (10)
Southern California (723)
Tennessee (32)
Texas (289)
Utah (56)
Virginia (47)
Washington D.C. (8)
Washington State (196)
West Virginia (1)
Wisconsin (19)
228,575 Results for "azzur group llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Positron Corporation Engages Skyline Corporate Communications Group, LLC to Enhance Investor Relations and Financial Community Outreach
January 14, 2025
·
4 min read
Genetown
Editas Medicine and Azzur Group Expand Partnership to Accelerate Editas’ Manufacturing Capabilities for Advancing the EDIT-301 Program Through Approval to Commercialization
Editas Medicine, Inc. and Azzur Cleanrooms on Demand™, an Azzur Group company, announced the companies have expanded their multi-year contract to support the scaling of EDIT-301, Editas Medicine’s experimental cell therapy medicine under investigation for the treatment of severe sickle cell disease and transfusion-dependent beta thalassemia, from approval to commercialization.
July 27, 2023
·
5 min read
Press Releases
Bionomics to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
October 15, 2024
·
2 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Press Releases
AIM ImmunoTech to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC
October 9, 2024
·
1 min read
News
CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC
October 8, 2024
·
1 min read
Press Releases
Palisade Bio to Participate in the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
October 8, 2024
·
1 min read
Press Releases
Autonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC
October 8, 2024
·
1 min read
Press Releases
Zevra Therapeutics to Participate in Rare Disease Panel at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
October 10, 2024
·
2 min read
Press Releases
TuHURA Biosciences (Nasdaq: HURA) Announces Webcast Replay of Panel Presentation at the 2024 Maxim Healthcare Virtual Summit, Presented by Maxim Group LLC
October 24, 2024
·
1 min read
1 of 22,858
Next
